Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow Reinvestment Rate
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $27.00K (capex $27.00K ) from operating cash flow of $59.59 Million. See how much free cash does Catalyst Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Catalyst Pharmaceuticals Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Catalyst Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see CPRX cash flow conversion.
Annual Cash Flow Reinvestment Rate for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year capital reinvestment analysis for Catalyst Pharmaceuticals Inc. See CPRX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $58.00K | $208.67 Million | $58.00K | ▼ -94.0% |
| 2024 | 0.00x | $1.11 Million | $239.81 Million | $556.00K | ▼ -99.8% |
| 2023 | 2.35x | $336.93 Million | $143.60 Million | $81.74 Million | ▲ +1313.2% |
| 2022 | 0.17x | $19.27 Million | $116.05 Million | $29.00K | ▼ -9.1% |
| 2021 | 0.18x | $11.02 Million | $60.37 Million | $1.02 Million | ▲ +63.7% |
| 2020 | 0.11x | $5.02 Million | $45.03 Million | $11.39K | ▼ -89.6% |
| 2019 | 1.08x | $37.26 Million | $34.61 Million | $19.37K | — |